US2811520A - Immodibenzyl compounds - Google Patents
Immodibenzyl compounds Download PDFInfo
- Publication number
- US2811520A US2811520A US2811520DA US2811520A US 2811520 A US2811520 A US 2811520A US 2811520D A US2811520D A US 2811520DA US 2811520 A US2811520 A US 2811520A
- Authority
- US
- United States
- Prior art keywords
- iminodibenzyl
- compounds
- bis
- propyl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title claims description 38
- -1 IMINODIBENZYL COMPOUNDS Chemical class 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 20
- 125000000217 alkyl group Chemical group 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 230000000875 corresponding Effects 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 125000004432 carbon atoms Chemical group C* 0.000 description 6
- 238000009833 condensation Methods 0.000 description 6
- 230000005494 condensation Effects 0.000 description 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 6
- SRTHRWZAMDZJOS-UHFFFAOYSA-N Lithium hydride Chemical compound [H-].[Li+] SRTHRWZAMDZJOS-UHFFFAOYSA-N 0.000 description 4
- ODZPKZBBUMBTMG-UHFFFAOYSA-N Sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 150000002829 nitrogen Chemical group 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- NALBLJLOBICXRH-UHFFFAOYSA-N Dinitrogen monohydride Chemical group N=[N] NALBLJLOBICXRH-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 210000004940 Nucleus Anatomy 0.000 description 2
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N Phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N Sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 150000003869 acetamides Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000005712 crystallization Effects 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000002005 ganglioplegic Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000003285 pharmacodynamic Effects 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- 229940075930 picrate Drugs 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Definitions
- a heterocyclic amine such as pyrrolidino, piperidino or morpholino
- a heterocyclic amine such as pyrrolidino, piperidino or morpholino
- a lower alkyl or lower alkoxy group is meant a group containing not more than 4 carbon atoms.
- the compounds may exist both in the racemic form and the com-pounds in such Various forms.
- one of the two symbols Z represents an acid residue sealed tube, particularly when the compound HN(-R)2 is a volatile amine.
- R represents a hydrogen atom or an alkyl group containing not more than 3 carbon atoms, and R and A have the meanings assigned to them above.
- T represents a- -CHO or CN group.
- the reaction may be carried out in the absence of the compound HN(R)2 to give directly the corresponding primary amine.
- Method 1 is the most advantageous. This reaction may be carried out in the presence or absence of a solvent and in the presence or absence of a condensing agent. It is however convenient to use an aromatic hydrocarbon solvent for example toluene or xylene, in the presence of a condensing agent, preferably selected from alkali metals and their derivatives (such as, for example, hydrides, amides, hydroxides, alcoholates, metal alkyls or aryls) and more particularly metallic sodium, sodamide, powdered sodium or potassium, lithium hydride, sodium tertbutylate, .butyllithium, and phenyllithium. The reaction is preferably carried out at the boiling temperature of the solvent.
- a condensing agent preferably selected from alkali metals and their derivatives (such as, for example, hydrides, amides, hydroxides, alcoholates, metal alkyls or aryls) and more particularly metallic sodium, sodamide, powdered sodium or potassium, lithium
- halogeno-diamine in the form of the free basein solution in, for example, benzene, toluene or xylene and to add it to the mixture of the other reactants in which the iminodibenzyl may already be present, at least in part, in the form of an alkali metal salt.
- the reaction may also be carried out using a salt of the halogeno-diamine but in this case a larger proportion of the condensing agent is preferably used in order to neutralise the acid of the salt employed.
- isomers may be separated, for example by crystallisation of a salt such as the dihydrochloride in alcohol, or by chromatography. It is not, however, essential to carry out this separation, since the two isomers generally have very similar pharmacodynamic properties.
- Example I A mixture: of imi-nodibenzyl (6.65 g.), toluene (35 cc.) and sodamide (1.52 g.) is heated under reflux for 1 hour under nitrogen and an 11.5% solution'(53 cc.) of 1:3- vbis-dimethylamino-Z-chloropropane in toluene is then added over 1 hour. A-fter being heated for 10 hours. under reflux, the mixture is cooled and washed with water cc.) The toluene solution is extracted with normal hydrochloric acid (70, 30, 20 and 20 cc.
- the oily product obtained is dissolved in diethylether and the ethereal solution extracted with dilute hydrochloric acid.
- the solution is then made alkaline with dilute caustic soda, extracted with cliethyl ether and the ether removed from the extract to yield the product (base) as an oil (1.17 g.) having the correct acidimetric titre.
- the 1:3-bis-dimethyla-mino-Z-propyl-iminodibenzyl-S- carboxylate used as starting material, of which the picrate has M. P. 174-175 0., can be prepared by condensing l:3abis-dimethylamino-Q-propanol with iminodibenzyl-S- carboxylic acid chloride, M. P. 120-121" C., itself prepared by the action of phosgene on iminodibenzyl.
- A represents the trivalent hydrocarbon group CHz-CHCH2'- the various nitrogen atoms being attached to any of the three free valencies thereof, and the groups R are lower alkyl groups and the acid addition salts, quaternary ammonium derivatives and addition compounds of any of the said compounds where the additional groups are pharmaceutically acceptable.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
United States ,IMINODIBENZYL COMPOUNDS Paul Gailliot, Paris, and Jean Robert, Gentilly, France,
assignors to Societe des Usines Chimiques Rhone- Poulenc, Paris, France, a French body corporate No Drawing. Application October 1, 1956,
Serial No. 612,966 1 Claims priority, application France October 26, 1955 4 Claims. (Cl. 260-239) Gilt-CH2 t 10 11\ 1 2 \5/ 3 N wherein A represents the trivalent hydrocarbon group the various nitrogen groups being attached to any of the three free valencies thereof and the groups R are the same or diiferent and represent when taken separately a hydrogen atom or a lower alkyl group and when taken together with the nitrogen atom (i. e. as the group --N(R)2) represent a residue of a heterocyclic amine such as pyrrolidino, piperidino or morpholino, corresponding compounds in which one or both of the benzene nuclei of 'the iminodibenzyl carry halogen, lower alkyl or lower alkoxy su-bstituent groups and the acid addition salts, the quaternary ammonium derivatives and the addition compounds (in particular with 8-chlorotheophyl1ine) of any .of the aforesaid compounds. By a lower alkyl or lower alkoxy group is meant a group containing not more than 4 carbon atoms.
When the group A contains an asymmetric carbon atom the compounds may exist both in the racemic form and the com-pounds in such Various forms.
The aforesaid new iminodibenzyl compounds are of tent:
value in. human therapy as gangl-ioplegics, local anaes-" as a substituent on the imino nitrogen atom by methods known per setor the introduction of such a substituent 2,811,520 Patented Oct. 29, 1957 2 grouping on a nitrogen atom, particularly a heterocyclic nitrogen atom. Such methods include:
(1) Condensation of a halogeno diamine of the type Hal (R)aN N (R) or one of its salts (where A and R have the meanings assigned to them above) with the appropriate iminodibenzyl.
(2) Condensation'of a compound H N(R)2 where R has the meaning set forth above, with an iminodibenzyl derivative of general Formula II:
Z Zi
where one of the two symbols Z represents an acid residue sealed tube, particularly when the compound HN(-R)2 is a volatile amine.
.(3) Heating, to effect decarboxylation, a compound of the general Formula III:
' CHrCHz (R)zN III where A and R have the meanings assigned to them above. (4) To produce compounds of general Formula I where the R groups are lower alkyl groups, alkylation of the corresponding compounds of Formula I where at least one of the R groups is replaced by a hydrogen atom, using methods of alkylation of amines known per se.
(5) Reduction of corresponding amides such as, for example the compounds of the general Formulae IV, V and VI:
CH2-CH2 oma).
GONCR):
where R represents a hydrogen atom or an alkyl group containing not more than 3 carbon atoms, and R and A have the meanings assigned to them above.
(6) Reduction in the presence of a compound HN( R)2 of a derivative of the general Formulae VII or VIII:
ens-on, @t it) where R has the meaning assigned to it above, A represents a grouping and T represents a- -CHO or CN group. When T is a --ON group, the reaction may be carried out in the absence of the compound HN(R)2 to give directly the corresponding primary amine.
(7) Cyclisation, preferably in a solvent selected from the class of substituted amides of' lower aliphatic acids such as formarnides or acetamides, in the presence of a condensing agent (e. g. alkali metal hydroxide or carbonate) and if desired in the presence of a catalyst such as copper powder, of a derivative of the general Formula IX:
N H Hal.
where A and R have the meanings assigned to them above and Hal is a halogen atom.
Method 1 is the most advantageous. This reaction may be carried out in the presence or absence of a solvent and in the presence or absence of a condensing agent. It is however convenient to use an aromatic hydrocarbon solvent for example toluene or xylene, in the presence of a condensing agent, preferably selected from alkali metals and their derivatives (such as, for example, hydrides, amides, hydroxides, alcoholates, metal alkyls or aryls) and more particularly metallic sodium, sodamide, powdered sodium or potassium, lithium hydride, sodium tertbutylate, .butyllithium, and phenyllithium. The reaction is preferably carried out at the boiling temperature of the solvent.
It is advantageous to use the halogeno-diamine in the form of the free basein solution in, for example, benzene, toluene or xylene and to add it to the mixture of the other reactants in which the iminodibenzyl may already be present, at least in part, in the form of an alkali metal salt. The reaction may also be carried out using a salt of the halogeno-diamine but in this case a larger proportion of the condensing agent is preferably used in order to neutralise the acid of the salt employed.
Isomerization may take place during the condensation and there is then obtained a mixture of varying proportions of the two isomers of Formulae X and XI:
OHrCHz N (iHg-ClT-CHzNCR):
These isomers may be separated, for example by crystallisation of a salt such as the dihydrochloride in alcohol, or by chromatography. It is not, however, essential to carry out this separation, since the two isomers generally have very similar pharmacodynamic properties.
The following examples in which the melting points indicated are determined on the Kofler bench, will serve to illustrate the invention but are not to be regarded as limiting it in any way:
Example I A mixture: of imi-nodibenzyl (6.65 g.), toluene (35 cc.) and sodamide (1.52 g.) is heated under reflux for 1 hour under nitrogen and an 11.5% solution'(53 cc.) of 1:3- vbis-dimethylamino-Z-chloropropane in toluene is then added over 1 hour. A-fter being heated for 10 hours. under reflux, the mixture is cooled and washed with water cc.) The toluene solution is extracted with normal hydrochloric acid (70, 30, 20 and 20 cc. successively) and the combined aqueous acid solutions are washed with ether (25 cc.) and then treated with aqueous sodium hydroxide (d -l.33; 16 cc.). They are then extracted with ether (3X50 cc.) and the combined ethereal extracts are, washed with water (30 cc.) and dried over sodium sulphate. The ether is removed on the water-bath and the residue is distilled in vacuo to give a mixture (6.14 g.) of 5- (2:3-bisdimethylamino- 1-propyl)iminodibenzyl and 5-;(1:3-bis-dimethylamino-2- propyl )iminodibenzyl. On dissolving this mixture in isopropanol and treating with ethanolic hydrogen chloride, there is obtained 5-(2:3*bis-dimethylamino-l-propyl)- iminodibenzyl hydrochloride, M. P. about 230-232 C.
By the action of methyl iodide on a solution in acetone of the base corresponding to this hydrochloride, the corresponding mono iodoniethylate is obtained, M. P. 182- 184" C. By following the procedure of this example but employing 1:3-bis-diethylamino-2-chloropropane there is obtained a mixture of 5-(2:3-bis-diethylamino-lpropyl)-iminodibenzyl and 5-(l'z3-bis-diethylamino-2- propyl)imin odibenzyl, the former isomer being in preponderantamount and have B. P. 0.11 164-l'68 C.
Example H l:3-bis-dimethylamino 2 propyl-iminodibenzyl-S-carboxylate (3.4 g.), M. P. 72 C., is heated gradually from 185 to 250 C. until evolution of carbon dioxide has ceased, which takes about an hour.. The oily product obtained is dissolved in diethylether and the ethereal solution extracted with dilute hydrochloric acid. The solution is then made alkaline with dilute caustic soda, extracted with cliethyl ether and the ether removed from the extract to yield the product (base) as an oil (1.17 g.) having the correct acidimetric titre. By addition of ethereal hydrogen chloride to an acetone solution of this base there is obtained 54(2z3-bis-dimethylamino-lpropyl)iminodibenzyl di hydroclrloride, P. 227- 229 C.
The 1:3-bis-dimethyla-mino-Z-propyl-iminodibenzyl-S- carboxylate used as starting material, of which the picrate has M. P. 174-175 0., can be prepared by condensing l:3abis-dimethylamino-Q-propanol with iminodibenzyl-S- carboxylic acid chloride, M. P. 120-121" C., itself prepared by the action of phosgene on iminodibenzyl.
We claim:
1. A compound selected from the class consisting of iminodibenzyl compounds of the general formula: I
CHr-CH', 10 11 wherein A represents the trivalent hydrocarbon group CHz-CHCH2'- the various nitrogen atoms being attached to any of the three free valencies thereof, and the groups R are lower alkyl groups and the acid addition salts, quaternary ammonium derivatives and addition compounds of any of the said compounds where the additional groups are pharmaceutically acceptable.
2, 5 2: 3-bis-dimethylamino-l-propyl) iminodibenzyl.
3. 5'( 1 3-bis-dimethy1amino-2-propyl)imincdibenzyl.
4. 5 (2:3 bis-diethylamino-l-propyl)iminodibenzyl.
References Cited in the file of this patent UNITED STATES PATENTS
Claims (1)
1. A COMPOUND SELECTED FROM THE CLASS CONSISTING OF IMINODIBENZYL COMPOUNDS OF THE GENERAL FORMULA:
Publications (1)
Publication Number | Publication Date |
---|---|
US2811520A true US2811520A (en) | 1957-10-29 |
Family
ID=3446723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US2811520D Expired - Lifetime US2811520A (en) | Immodibenzyl compounds |
Country Status (1)
Country | Link |
---|---|
US (1) | US2811520A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2948732A (en) * | 1960-08-09 | N-heterocyclic compounds | ||
US3133936A (en) * | 1961-02-20 | 1964-05-19 | Olin Mathieson | Dihydrodibenzoxazepines |
US3221011A (en) * | 1962-12-17 | 1965-11-30 | Sandoz Ltd | Dibenzazepine derivatives |
US3472866A (en) * | 1966-01-13 | 1969-10-14 | Fisons Pest Control Ltd | Substituted benzimidazole compounds |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2554736A (en) * | 1951-05-29 | Tertiary aminoalkyl-iminodibenzyls | ||
US2764580A (en) * | 1956-09-25 | Process for the production of |
-
0
- US US2811520D patent/US2811520A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2554736A (en) * | 1951-05-29 | Tertiary aminoalkyl-iminodibenzyls | ||
US2764580A (en) * | 1956-09-25 | Process for the production of |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2948732A (en) * | 1960-08-09 | N-heterocyclic compounds | ||
US3133936A (en) * | 1961-02-20 | 1964-05-19 | Olin Mathieson | Dihydrodibenzoxazepines |
US3221011A (en) * | 1962-12-17 | 1965-11-30 | Sandoz Ltd | Dibenzazepine derivatives |
US3472866A (en) * | 1966-01-13 | 1969-10-14 | Fisons Pest Control Ltd | Substituted benzimidazole compounds |
US3472865A (en) * | 1966-01-13 | 1969-10-14 | Fisons Pest Control Ltd | Substituted benzimidazole compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2916490A (en) | Ocjhs | |
US2636032A (en) | N, n'-disubstituted piperazines and process of preparing same | |
US2971001A (en) | Quaternary salts of triphenylethanols, -ethylenes, and -ethanes | |
US2811520A (en) | Immodibenzyl compounds | |
US3318901A (en) | N-dialkylaminoalkyl-1-xanthenylpiper-idinecarboxamides and related compounds | |
US2732373A (en) | Basic heterocyclic ethers | |
US2830048A (en) | alpha, beta (disubstituted aminoalkyl) acetylenes | |
DE69413213T2 (en) | PIPERAZINE DERIVATIVES AS 5-HT1A LIGANDS | |
US2745837A (en) | Benzhydryl ethers of alkyl piperidinols | |
US3270004A (en) | Disubstituted piperazines useful as schistosomiasis agents | |
US3156688A (en) | Nu-alkyl and nu-aralkyl benzoxacycloalkanemethylamines | |
US2833770A (en) | Chj-chj | |
US3317538A (en) | 4, 4'-diamino-butyrophenones | |
US2483998A (en) | Nu-(pyrrolidylalkyl)-phenothiazines | |
US2776282A (en) | Cyclic amides of alpha-toluic acids and derivatives thereof | |
US2894947A (en) | Phenthiazine derivatives | |
US3164601A (en) | Analeptically active n-substituted aminonorcamphane derivatives and their acid addition salts and quaternary ammonium compounds | |
US2997472A (en) | Certificate of correction | |
US2887484A (en) | Benzodioxan derivatives | |
US2771469A (en) | Quaternary ammonium salts of deltahydrocarbyoxyphenyl gamma-hydroxy amines | |
US3285912A (en) | Substituted diphenyl ketones | |
US2997468A (en) | Preparation of phenothiazines | |
DE2300543A1 (en) | Aryloxypropanolamine derivs - with spasmolytic, anti-Parkinsonism and beta-adrenergic blocking activity | |
US2753345A (en) | Substituted mercaptobenzoic acids and methods of preparing the same | |
US3124577A (en) | Hydroxyalkyl cyclic amlno |